Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Plant Allergenic Extract [EPC]
Cinchona Bark is a botanical source of alkaloids like quinine and quinidine, utilized clinically as a non-standardized allergenic extract for diagnostic testing and historically for its antimalarial properties.
Name
Cinchona Bark
Raw Name
CINCHONA BARK
Category
Non-Standardized Plant Allergenic Extract [EPC]
Drug Count
6
Variant Count
6
Last Verified
February 17, 2026
About Cinchona Bark
Cinchona Bark is a botanical source of alkaloids like quinine and quinidine, utilized clinically as a non-standardized allergenic extract for diagnostic testing and historically for its antimalarial properties.
Detailed information about Cinchona Bark
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Cinchona Bark.
While the purified alkaloids derived from the bark (like Quinine Sulfate) have specific FDA-approved indications for malaria, the raw bark extract itself is primarily used in the context of allergy and immunology. It belongs to a class of drugs called allergenic extracts, which are used to diagnose or treat allergic diseases. The FDA history of Cinchona is complex; while the purified alkaloids were some of the first substances to receive formal regulatory scrutiny, the raw bark remains a 'non-standardized' extract, meaning its potency is not measured against a specific US reference standard. Healthcare providers must exercise extreme caution when interpreting results from these extracts due to the inherent variability in botanical compositions.
The mechanism of action for Cinchona Bark depends entirely on its clinical application. When used as an allergenic extract, it works by eliciting a controlled immune response. In a sensitized individual, the proteins or chemical constituents in the Cinchona extract bind to specific Immunoglobulin E (IgE) antibodies located on the surface of mast cells and basophils (types of white blood cells). This binding triggers the release of inflammatory mediators like histamine, which produces a localized 'wheal and flare' reaction (a bump and redness). This reaction allows clinicians to confirm a patient's allergy to the substance.
At a molecular level, the primary active alkaloids within the bark—quinine and quinidine—have distinct pharmacological profiles. Quinine acts as a blood schizonticide (killing the parasite in the blood) by interfering with the malaria parasite's ability to process hemoglobin. Specifically, it inhibits the polymerization of toxic heme into non-toxic hemozoin, leading to the parasite's death. Quinidine, a diastereomer of quinine, acts as a Class Ia antiarrhythmic agent by blocking fast inward sodium channels in cardiac myocytes (heart cells), thereby slowing conduction velocity and prolonging the action potential duration. In the context of the raw bark extract, these alkaloids contribute to both the therapeutic potential and the significant toxicity profile of the substance.
The pharmacokinetics of Cinchona Bark are generally described through its primary alkaloid, quinine, as the raw bark is rarely used in standardized oral dosing in modern medicine.
Cinchona Bark and its derivatives have several distinct uses in clinical and diagnostic medicine:
Cinchona Bark is available in several forms, though many are restricted to specific clinical or industrial settings:
> Important: Only your healthcare provider can determine if Cinchona Bark or its derivatives are right for your specific condition. The use of raw bark carries significant risks of toxicity and unpredictable dosing.
Because Cinchona Bark is classified as a Non-Standardized Allergenic Extract, there is no 'standard' oral dose for systemic treatment. Its use is strictly regulated based on the application:
Cinchona Bark extracts and purified derivatives must be used with extreme caution in children.
In patients with significant kidney disease, the clearance of Cinchona alkaloids is reduced. For purified quinine, the dosing interval may need to be extended to every 12 hours if the creatinine clearance is below 30 mL/min. Raw bark should be avoided entirely in patients with renal failure.
Since the liver is the primary site of metabolism (via CYP3A4), patients with cirrhosis or hepatitis are at a significantly increased risk of alkaloid toxicity. Doses should be reduced by 25-50%, and close monitoring for 'cinchonism' (toxicity symptoms) is required.
Geriatric patients often have reduced renal and hepatic reserve. They are also more susceptible to the cardiac side effects of Cinchona (such as QT prolongation). Lower starting doses and frequent EKG monitoring are recommended if Cinchona derivatives are used.
If you are taking a Cinchona-derived medication for an infection and miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and return to your regular schedule. Do not double the dose to catch up, as this significantly increases the risk of cardiac arrhythmias.
Cinchona overdose is a medical emergency. Signs of acute toxicity include:
In the event of an overdose, call 911 or your local emergency services immediately. Emergency treatment often involves gastric lavage, activated charcoal, and intensive cardiac monitoring.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop a prescribed course of Cinchona-derived medication without medical guidance.
The most characteristic side effect profile of Cinchona Bark is a cluster of symptoms known as Cinchonism. Even at therapeutic doses, many patients will experience:
> Warning: Stop taking Cinchona Bark and call your doctor immediately if you experience any of these life-threatening symptoms.
Prolonged exposure to Cinchona Bark alkaloids can lead to permanent damage in some organ systems. Chronic cinchonism can result in permanent high-frequency hearing loss and optic atrophy (death of the optic nerve). There is also a risk of developing chronic 'Blackwater Fever,' a severe complication of malaria treatment where red blood cells burst, leading to hemoglobin in the urine and potential kidney failure.
While the raw bark itself does not have a formal 'Black Box' label (as it is a non-standardized extract), the FDA has issued a Drug Safety Communication that functions similarly for its primary component, Quinine.
FDA WARNING: Quinine (and by extension, Cinchona Bark) should NOT be used for the treatment or prevention of nocturnal leg cramps. This use is not FDA-approved and has been linked to serious, permanent, and fatal adverse reactions, including severe thrombocytopenia (low platelets) and hemolytic uremic syndrome. The risks of using this substance for leg cramps far outweigh any potential benefits.
Report any unusual symptoms or changes in your health to your healthcare provider immediately.
Cinchona Bark is a potent pharmacological agent that must be handled with the same caution as synthetic drugs. Because it contains alkaloids that affect the heart, blood, and nervous system, it should never be used as a 'natural' alternative without professional medical oversight. Patients with a history of heart rhythm disorders or blood cell abnormalities must be particularly vigilant.
There are no specific Black Box warnings for the Non-Standardized Allergenic Extract of Cinchona Bark. However, the FDA has mandated severe warnings for Quinine (the primary active ingredient in Cinchona). These warnings state that Quinine must not be used for leg cramps due to the risk of life-threatening hematologic (blood) reactions. Healthcare providers are instructed that Quinine is only indicated for the treatment of specific types of malaria.
If a patient is prescribed Cinchona-derived medications, the following monitoring is typically required:
Cinchona Bark can cause significant dizziness, blurred vision, and confusion (Cinchonism). Do not drive, operate heavy machinery, or engage in hazardous activities until you know how this substance affects you. Visual disturbances can be sudden and severe.
Alcohol should be avoided when using Cinchona Bark. Alcohol can exacerbate the gastrointestinal side effects and increase the risk of dizziness and confusion. Furthermore, many people are exposed to Cinchona via 'mixers' like tonic water; if you have a known Cinchona allergy, you must avoid all beverages containing 'quinine' or 'cinchona extract.'
If you are taking Cinchona derivatives for a parasitic infection, you must complete the full course even if you feel better. Stopping early can lead to a relapse of the infection. However, if you experience signs of an allergic reaction or low platelets (bruising/bleeding), you must stop the medication immediately and seek emergency care.
> Important: Discuss all your medical conditions, especially heart, kidney, or blood disorders, with your healthcare provider before starting Cinchona Bark.
Cinchona Bark and its alkaloids should NEVER be used with the following medications due to the risk of fatal heart rhythm disturbances:
Cinchona Bark can interfere with several laboratory tests:
For each major interaction, the clinical consequence is usually an increased risk of toxicity (due to decreased clearance) or reduced efficacy (due to increased metabolism). Management typically involves dose adjustment or selecting an alternative medication.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter 'bitters' or tonics.
Cinchona Bark and its derivatives must NEVER be used in the following circumstances:
These conditions require a careful risk-benefit analysis by a physician:
Patients who are allergic to Quinine are almost certainly allergic to Quinidine and raw Cinchona Bark. There is also a potential for cross-sensitivity with other cinchona alkaloids like cinchonine. Patients with a known allergy to tonic water should be flagged as 'Cinchona-allergic' in medical records.
> Important: Your healthcare provider will evaluate your complete medical history, including any previous reactions to 'bitter' drinks or malaria medications, before prescribing Cinchona Bark.
Cinchona Bark is generally considered unsafe during pregnancy.
Cinchona alkaloids are excreted into breast milk in small amounts. While the levels are generally considered too low to harm a healthy infant, there is a theoretical risk for infants with G6PD deficiency, who may develop hemolysis. Breastfeeding mothers should consult their doctor; if Cinchona is necessary, the infant should be monitored for jaundice or dark urine.
Cinchona Bark is not approved for general use in children. Its use as an allergenic extract is limited to specialist settings. In pediatric malaria, purified quinine is used, but children are more susceptible to the toxic effects on the central nervous system and the heart. Safety and effectiveness in children under the age of 16 for any use other than malaria have not been established.
Elderly patients are at the highest risk for Cinchona-related complications.
In patients with a GFR (Glomerular Filtration Rate) less than 30 mL/min, the clearance of Cinchona alkaloids is reduced by approximately 50%. Dosing must be adjusted accordingly, and these patients should be monitored daily for signs of tinnitus or visual changes.
Patients with Child-Pugh Class B or C hepatic impairment should avoid Cinchona Bark if possible. If it must be used, a 25% to 50% dose reduction is typically required, as the liver cannot efficiently metabolize the alkaloids, leading to rapid toxicity.
> Important: Special populations, particularly pregnant women and the elderly, require individualized medical assessment before any exposure to Cinchona.
Cinchona Bark contains over 30 different alkaloids. The primary mechanism of action for its most famous constituent, Quinine, involves the inhibition of heme polymerase in Plasmodium parasites. By preventing the detoxification of heme (a byproduct of hemoglobin digestion), the parasite is poisoned by its own waste.
In human physiology, the alkaloids act as membrane stabilizers. They block sodium channels (Class Ia antiarrhythmic effect) and potassium channels. This slows the 'upstroke' of the action potential in the heart and nerves. Additionally, Cinchona alkaloids have an antipyretic (fever-reducing) effect by acting on the hypothalamus and an analgesic (pain-relieving) effect, though the exact pathways for these are less defined than modern NSAIDs.
The dose-response relationship for Cinchona is narrow, meaning the difference between a therapeutic dose and a toxic dose is small. The onset of action for oral forms is approximately 1-2 hours, with effects lasting for 6-8 hours. Tolerance to the antimalarial effects does not typically develop, but 'resistance' from the parasite is a major global health concern.
| Parameter | Value (Quinine) |
|---|---|
| Bioavailability | 76% - 95% |
| Protein Binding | 70% - 90% (Alpha-1-acid glycoprotein) |
| Half-life | 8 - 12 hours (Adults) |
| Tmax | 1 - 3 hours |
| Metabolism | Hepatic (Primary: CYP3A4) |
| Excretion | Renal (20% unchanged), Fecal (<5%) |
Cinchona Bark is classified as a Non-Standardized Plant Allergenic Extract. Its purified derivatives are classified as Antimalarials (Quinine) and Class Ia Antiarrhythmics (Quinidine). It is the 'parent' substance for the synthetic aminoquinoline class of drugs, which includes Chloroquine and Hydroxychloroquine.
Common questions about Cinchona Bark
Cinchona Bark is primarily used today as a source for the alkaloids quinine and quinidine, which treat malaria and certain heart rhythm disorders, respectively. In a diagnostic setting, it is used as a non-standardized allergenic extract to test for allergies to the plant or its derivatives. Historically, it was a major treatment for fevers and digestive issues, but these uses have been replaced by safer medications. In the food industry, it is used in very small, regulated amounts to provide the bitter flavor in tonic water. It should never be used for self-treatment of any condition without a doctor's supervision.
The most common side effects are grouped together in a syndrome called 'cinchonism.' This includes ringing in the ears (tinnitus), headache, nausea, dizziness, and slight changes in vision. These symptoms can occur even with standard doses and are usually a sign that the drug levels are reaching a toxic range. More severe side effects include a dangerous drop in blood platelets, which can cause internal bleeding. If you experience bruising, bleeding, or severe ringing in the ears, you should contact a healthcare provider immediately. Most mild symptoms resolve once the substance is discontinued.
No, you should avoid drinking alcohol while taking Cinchona Bark or its derivatives. Alcohol can worsen the gastrointestinal side effects like nausea and vomiting and may increase the risk of dizziness and confusion associated with cinchonism. Furthermore, many people consume Cinchona through 'mixers' like tonic water in alcoholic drinks; if you have a Cinchona allergy, this combination can be life-threatening. Alcohol may also interfere with the liver's ability to process the alkaloids, potentially leading to higher, more toxic levels in your bloodstream. Always consult your doctor regarding dietary restrictions while on medication.
Cinchona Bark is generally considered unsafe during pregnancy and should be avoided unless absolutely necessary for treating life-threatening malaria. It has been linked to birth defects, including permanent hearing and vision loss in the baby. Historically, it was used to induce abortions because it can cause the uterus to contract, which poses a high risk of miscarriage or premature birth. Additionally, it can cause dangerously low blood sugar in pregnant women. If you are pregnant or planning to become pregnant, you must discuss the risks of Cinchona with your obstetrician before any exposure.
When taken orally as a purified extract, Cinchona alkaloids are absorbed quickly, with peak levels in the blood occurring within 1 to 3 hours. For the treatment of malaria, symptoms like fever may begin to improve within 24 to 48 hours of starting treatment. However, the full course of medication must be completed to ensure the parasite is entirely cleared from the body. In the context of allergy testing, the reaction to a Cinchona extract is much faster, usually appearing as a skin bump within 15 to 30 minutes. The duration of the effect in the body is typically 6 to 12 hours per dose.
If you are taking Cinchona-derived medication for a prescribed reason, such as malaria, you should not stop taking it suddenly without consulting your doctor. Stopping early can allow the infection to return or lead to drug resistance. However, if you experience signs of a serious allergic reaction, unusual bleeding, or severe vision changes, you must stop the medication immediately and seek emergency medical help. These symptoms may indicate a life-threatening reaction like thrombocytopenia. Your doctor will provide a safe plan for discontinuation based on your specific health needs and the reason you are taking the drug.
If you miss a dose of a Cinchona-derived medication, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and continue with your regular timing. You should never take two doses at once to make up for a missed one, as this significantly increases the risk of heart rhythm problems and cinchonism. Maintaining a consistent level of the drug in your blood is important for treating infections, so try to take it at the same time each day. If you miss multiple doses, contact your healthcare provider for specific instructions on how to resume your treatment.
There is no clinical evidence to suggest that Cinchona Bark causes weight gain. In fact, many of its common side effects, such as nausea, vomiting, and loss of appetite, are more likely to lead to temporary weight loss during treatment. If you notice significant weight changes while taking this medication, it is more likely due to the underlying condition being treated (such as a severe infection) or another unrelated health issue. Always report unexpected weight changes to your doctor. You should not use Cinchona Bark for weight management, as the alkaloids it contains are toxic at the levels required to suppress appetite.
Cinchona Bark has many serious drug interactions and should only be taken with other medications under strict medical supervision. It can interact dangerously with heart medications like digoxin, blood thinners like warfarin, and certain antipsychotics. These interactions can lead to fatal heart rhythms or severe bleeding. It also interacts with many common antibiotics and antacids. Because it is processed by the CYP3A4 enzyme in the liver, many other drugs can either increase or decrease its concentration in your blood. Always provide your doctor with a complete list of all prescriptions, over-the-counter drugs, and herbal supplements you are using.
Cinchona Bark itself is a natural botanical product and is available in various non-prescription forms like powders and tinctures, but these are not standardized for medical use. The purified alkaloid derived from it, Quinine Sulfate, is available as a generic medication (324 mg capsules) and is FDA-approved for malaria. Quinidine is also available in generic forms for heart rhythm issues. While generic versions are generally more affordable, they require a prescription and should only be used for their FDA-approved indications. Do not substitute raw bark supplements for prescription-strength generic quinine, as the dosage is unpredictable and potentially dangerous.